Invitation - NeoDynamics presents preclinical results on March 17 at 13.00 CET
STOCKHOLM, March 15, 2021 /PRNewswire/ -- NeoDynamics AB (publ) presents an abstract on preclinical results with its novel biopsy system NeoNavia at the St Gallen International Breast Cancer Conference 2021, which is held March 17-21, 2021 in Vienna.
In light of this event, NeoDynamics and Redeye are organizing a parallel digital presentation for the financial markets on Wednesday March 17 at 13.00 - 14.00 CET where CEO Anna Eriksrud and Dr Kai-Uwe Schässburger, Head of Clinical Development & Medical Affairs, will present the results and comment on the launch of the product. The presentation will be followed by a Q&A session led by Redeye's analyst Oskar Bergman.
Please register to participate at Redeye at the following link: https://www.lyyti.in/Strategy_Update_NeoDynamics_9010
The presentation will be held in English.
The abstract will also be published in the scientific journal The Breast.
For further information, please contact:
Anna Eriksrud, CEO NeoDynamics AB. Phone +46 708 444 966
e-mail: [email protected]
This information was brought to you by Cision http://news.cision.com
SOURCE NeoDynamics
![](https://rt.prnewswire.com/rt.gif?NewsItemId=IO09369&Transmission_Id=202103150438PR_NEWS_USPR_____IO09369&DateId=20210315)
Share this article